Please provide your email address to receive an email when new articles are posted on . Angling a patient’s face can negate the effect of facial contour on visual field testing. AI may help predict ...
The strategic collaboration between ZEISS Medical Technology and Envision Health Technologies combines ZEISS’ long-term innovation strategy and leadership in visual field testing with Envision’s ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Black and multiracial children had significantly lower ...
Ambient Interactive ZEST EX (AIZE-EX) is a newly developed, time-saving visual field (VF) test algorithm for follow-up assessments in glaucoma patients that utilizes prior AIZE results. This study ...
Glaucoma is the second-leading cause of blindness worldwide, and is currently incurable.
Mathematical models have been widely utilized in the field of science. These models are based on empirical testing and theory, attempting to simplify and describe complex processes using mathematical ...
Zeiss Medical Technology has formed a strategic collaboration with digital eye health company, Envision Health Technologies, ...
ZEISS Medical Technology, one of the world's leading medical technology companies, today announced a strategic collaboration ...
The COVID-19 pandemic made it clear that we need novel solutions for monitoring patients with chronic diseases such as glaucoma. One area that is particularly ripe for disruption is perimetry testing.
Perimetry, also known as visual field testing, is an essential diagnostic tool for assessing various ophthalmic conditions, including glaucoma, optic neuropathies, and disorders affecting the retina ...
Glaucoma is often called the "silent thief of sight" because it can gradually damage vision for years before noticeable ...
Higher mean blood pressure (BP) levels were associated with faster rates of visual field progression in patients with glaucoma, according to a retrospective cohort study. Among 985 patients, the ...